PRKRA Antibody (S246) Blocking Peptide

The synthetic peptide sequence used to generate the antibody was selected from the S246 region of human PRKRA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

[Interferon-inducible double-stranded RNA-dependent protein kinase activator A; Interferon-inducible double-stranded RNA-dependent protein kinase activator A; interferon-inducible double-stranded RNA-dependent protein kinase activator A; protein activator of interferon induced protein kinase EIF2AK2; PKR-associated protein X; PKR-associating protein X; Protein activator of the interferon-induced protein kinase; Protein kinase, interferon-inducible double-stranded RNA-dependent activator]